Diagnostic and therapeutic challenges of treating opportunistic fungal cellulitis: a case series

Autor: Jed Paul, Mary M. Czech, Ramya Balijepally, Janice Wes Brown

Publikováno v: BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-7 (2022)

Abstract Background Cellulitis is an infection most commonly caused by bacteria and successfully treated with antibiotics. However, certain patient populations, especially the immunocompromised, are at risk for fungal cellulitis, which can be misiden

Externí odkaz: https://doaj.org/article/0e93c45bc6fe40ac89b8dedc280b5b9e

Disseminated Tuberculosis With an Atypical Cutaneous Manifestation in a Hematopoietic Cell Transplant Patient in the Early Posttransplant Period: Case Report and Review of the Literature

Autor: Mary M Czech, Maria Veronica Dioverti, Andrew H Karaba, Tania Jain, Sai M Talluru, Joel C Sunshine, Jun Kang, Nikki Parrish, Olivia S Kates

Publikováno v: Open Forum Infectious Diseases. 9

We describe an unusual case of posttransplant tuberculosis reactivation in a man who underwent allogeneic hematopoietic cell transplant. Concomitant with disseminated adenovirus infection, reactivation of tuberculosis manifested as disseminated, nonf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b42578c93b7b68f19e85727fc1765f93
https://doi.org/10.1093/ofid/ofac643

Cefiderocol: A New Cephalosporin Stratagem Against Multidrug-Resistant Gram-Negative Bacteria

Autor: Marisa Holubar, Sharon Ong'uti, Mary M Czech, Elizabeth Robilotti

Publikováno v: Clin Infect Dis

Cefiderocol is a novel injectable siderophore cephalosporin that hijacks the bacterial iron transport machinery to facilitate cell entry and achieve high periplasmic concentrations. It has broad in vitro activity against gram-negative bacteria, inclu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aac52534dc8c87cfa97341c19487fd2c
https://pubmed.ncbi.nlm.nih.gov/34492098

Concurrent Trypanosoma cruzi and Cytomegalovirus Reactivation in an Immunosuppressed Patient With Limited Cutaneous Systemic Sclerosis

Autor: Timothy Almazan, Jennifer Y. Wang, Roberto A. Novoa, Brian G. Blackburn, Gordon H. Bae, Niaz Banaei, Hannah Wang, Shyam S. Raghavan, Kerri E. Rieger, Mary M Czech, Michael S. Chang

Publikováno v: The American Journal of Dermatopathology.

Chagas disease, a multisystem infection caused by the protozoan Trypanosoma cruzi, is primarily found in Latin America. In recent years, prevalence has increased in the United States, where reactivation is the most common clinical scenario. Here, we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6bd3e3c5004bb69105fe19628f859e5
https://doi.org/10.1097/dad.0000000000001842

Opportunistic Infections, Mortality Risk, and Prevention Strategies in Patients With Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome.

Autor: Czech M; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Cuellar-Rodriguez J; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Patel BA; National Heart, Blood, and Lung Institute, National Institutes of Health, Bethesda, Maryland, USA., Groarke EM; National Heart, Blood, and Lung Institute, National Institutes of Health, Bethesda, Maryland, USA., Cowen EW; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Turturice B; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Beck DB; Department of Medicine and Department of Biochemistry and Molecular Pharmacology, New York University, New York, New York, USA.; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Wilson L; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Goodspeed W; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Darden I; National Heart, Blood, and Lung Institute, National Institutes of Health, Bethesda, Maryland, USA., Young NS; National Heart, Blood, and Lung Institute, National Institutes of Health, Bethesda, Maryland, USA., Hickstein D; National Heart, Blood, and Lung Institute, National Institutes of Health, Bethesda, Maryland, USA., Ombrello A; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Hoffman P; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Arikan EA; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Sinaii N; Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Hathaway L; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Castelo-Soccio L; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Fike A; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Kastner DB; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Grayson PC; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Ferrada MA; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.; Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Jul 23; Vol. 11 (7), pp. ofae405. Date of Electronic Publication: 2024 Jul 23 (Print Publication: 2024).